H M Pharma - Life Science Product Development, Patenting and Business Development

HM Pharma Consultancy provides expert assistance to pharmaceutical and biotechnology companies in the most crucial areas of the industry. We offer drug and diagnostic development services, and can assist with pre-clinical and early-stage clinical drug development.

HM Pharma Consultancy's business development support specializes in helping US and Asian life science companies introduce their drug or medical device products to European Union markets; we assist with building regulatory dossiers, writing applications for reimbursement and identifying distributors.

Complete integration of these three key areas – product development, patenting, and business development - is our unique strength.

Pre-clinical drug development and early-stage clinical drug development

We can help with the design, organization and monitoring of pre-clinical and early-stage clinical drug, medical device and diagnostics development projects. Our intellectual property services offers expert advice concerning strategic patenting, proper drafting of patent applications, and can help with infringement analyses and opposition proceedings.

Drug development services and diagnostic development services

Whether you are a virtual life science company with a nascent drug development project, an emerging company with a preclinical candidate compound that needs to be advanced to clinical Phase I trials, or a larger company needing assistance with specific aspects of clinical trials, HM Pharma Consultancy is the right partner when you require drug development services and diagnostic development services.

Drugs, cell therapies, medical devices and diagnostics in the following fields are our special focus in the drug development services and diagnostic development services sectors:

• Central and peripheral nervous system: psychiatry (dementia, schizophrenia, mood disorders, addiction) and neurology (stroke, traumatic brain or spinal cord injuries, epilepsy, motor disorders such as Parkinson's disease or multiple sclerosis, and pain)
• Eye medicine (ophthalmology) in all its many facets, including surgical procedures
• Cardiorespiratory medicine (with a focus on myocardial infarction, heart failure, pulmonary hypertension and cardiopulmonary imaging)
• Urology (kidney and bladder disorders)
• Viral infection

Our drug and diagnostic development services in all these areas are supported by a thorough knowledge of the scientific literature and the international patent landscape, driven by our therapy-centred internal knowledge databases, which are unique in their comprehensive coverage.

Intellectual property services

While those concerned with corporate patenting - inventors, management, and patent attorneys - all give their very best input, their backgrounds and perspectives are so diverse that not "speaking a common language" is an impediment, although that might not even be apparent.

H.M. Pharma Consultancy can assist significantly in the realization of the full potential of inventions by working with all parties involved in the patenting process. Specifically, our offers include the following:

• Surveying markets for unmet therapeutic need and patenting opportunities - is there something emerging from our work that we should patent, but might not fully aware of at this time?
• Freedom to Operate searches – can you go ahead with your project without being blocked by third parties' patents or risking an infringement suit?
• Vigilance within your existing patent portfolio – is anybody infringing or working around your intellectual property?
• Comprehensive assistance with writing patent applications and with drafting replies to patent office actions
• Managing patent portfolios in co-operation with your patent attorneys

Life sciences business development services

In life sciences, business development means things as diverse as evaluating novel technologies for commercial potential, licensing of product and patent rights, identifying and developing new market niches, and optimizing commercial strategies.

H.M. Pharma Consultancy's unified network approach to business development provides a unique perspective which emerges from the complete integration of all available sources of information.

Strategic:

• Identifying license opportunities and potential corporate or academic partners
• Assisting in due-diligence procedures and strategic portfolio analyses
• Discovering non-obvious opportunities in your portfolio: drug repurposing

Operative:

• Advising and compiling regulatory dossier and drug reimbursement in Europe
• Monitoring and analyzing competitor information in near real time, using integrated intelligence collection approaches